|
Grigorieva E.V., Stolyarevich E.S., Starikov D.V., Magdeeva N.A., Kondrashova I.A., Zhokhova T.P., Pasechnaya N.V.
Rheumatoid arthritis? Systemic lupus erythematosus? – Fabry disease
|
№2 / 2025
|
|
Moiseev S.V., Shchulkin A.V., Abalenikhina Yu.V., Mylnikov P.Yu., Yakusheva E.N., Khmelevsky M.S., Matsiyak M.V.
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers
|
№3 / 2023
|
|
A.A. Ilyushkina, G.V. Baydakova, I.O. Bychkov, N.A. Buruleva, E.Yu. Zakharova
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
|
№2 / 2020
|
|
T.V. Kirsanova, O.V. Khoroshkeeva, E.S. Kamyshova, N.V. Sharashkina, N.K. Tetruashvilli
Successful pregnancy in a patient with Fabry disease and predominant renal involvement
|
№1 / 2016
|
|
V.V. Fomin, A.A. Pulin, O.A. Aksenova, T.Yu. Kustova, S.S. Girina, S.V. Roschupkina, V.A. Kudravtsev, V.A. Varshavskii, E.P. Golitsina, I.V. Damulin, V.V. Panasiuk, N.A. Mukhin
Severe podocyte damage in asymptomatic patient with Fabry disease
|
№1 / 2012
|
|
V.V. Fomin, A.A. Pulin, V.V. Rameev, V.P. Sedov, A.D. Meshkov, S.V. Roschupkina, V.V. Panasiuk, L.V. Kozlovskaya, N.A. Moukhin
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
|
№5 / 2010
|
|
V.V. Fomin, A.A. Pulin
Nephropathy in Fabry disease: opportunities of dramatic prognosis improvement
|
№1 / 2010
|
Русский
